Earnings Summary

SQZ Biotechnologies Co’s revenue fell -100% since last year same period to $0Mn in the Q1 2023. On a quarterly growth basis, SQZ Biotechnologies Co has generated -100% fall in its revenue since last 3-months.

SQZ Biotechnologies Co’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a 1.2% jump from last quarter’s estimates.

SQZ Biotechnologies Co’s earning per share (EPS) estimates for the current year stand at -0.82.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. SQZ Biotechnologies Co’s return on assets (ROA) stands at -0.33.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. SQZ Biotechnologies Co’s return on equity (ROE) stands at -1.05.